Skip to content

Extended Pessary Interval for Care (EPIC Study)

Extended Pessary Interval for Care (EPIC Study): Patient Preference for 3 Verus 6 Month Follow-up

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01644214
Acronym
EPIC
Enrollment
13
Registered
2012-07-19
Start date
2016-11-30
Completion date
2020-03-31
Last updated
2019-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse, Pessary

Keywords

Pelvic organ prolapse, Pessary

Brief summary

Objectives: Pelvic organ prolapse (POP) is a common condition for which pessaries are commonly used in conservative treatment. Despite their prevalence, there is no literature to guide the management of pessaries. Our objective is to determine whether patients managed with a pessary for POP are more satisfied with follow-up at 3 or 6 month intervals and if there is any difference in complications rates between the two groups. Hypothesis: The investigators hypothesize that there will be higher patient satisfaction in the group randomized to 6 month follow-up intervals and that there will be no difference in complication rates between the two follow-up groups. Method: The investigators will conduct a prospective randomized control trial comparing patient satisfaction and complication rates between patients with pessaries randomized to either 3 or 6 month follow-up intervals over 1 year.

Interventions

OTHER6 month follow up for pessary check in the clinic setting

The standard of care is considered to be pessary checks every 3 months, therefore those that are checked every 6 months will be considered to be in the intervention group.

Sponsors

Women's College Hospital
CollaboratorOTHER
Mount Sinai Hospital, Canada
CollaboratorOTHER
Unity Health Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Females with POP who have opted for conservative management with a pessary * Able to read and write English * First time pessary users * Successful fitting with a covered ring or Gellhorn pessary, as determined at the usual early follow-up visit 2-4 weeks after initial fitting (successful defined as: no expulsion on movement, squatting or valsalva, no urinary retention, no discomfort, and still retained pessary after 2 weeks) * Patients agree to use vaginal estrogen (either tablet or cream twice weekly) during the study period; patients may not use a vaginal estrogen ring since this requires changing every 3 months, and will interfere with the study follow-up schedule

Exclusion criteria

* Current presence of vaginal bleeding, vaginal abrasions or ulcers, or vaginal infection * Significant cognitive impairment * Pessary used for indication other than POP (ie. urinary incontinence) * Use of a pessary that is not a covered ring or Gellhorn (i.e exclude cube, donut, etc.) * Contraindications to vaginal estrogen * Unsuccessful pessary fitting (successful defined as: no expulsion on movement, squatting or valsalva, no urinary retention, no discomfort, and still retained pessary after 2 weeks)

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfactionAt 6 months from study enrollmentTo determine if patients managed with a pessary for POP are more satisfied with follow-up at 6 or 12 weeks over a one year period.

Secondary

MeasureTime frameDescription
Pessary associated complicationsChecked at all follow-up visits (3 and 6 months, depending on study group)To determine if there is a difference in complication rates associated with indwelling pessaries between those that are seen at 6 week intervals and those that are seen at 12 week intervals, over a one year time period.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026